ASLAN Pharmaceuticals(ASLN) - 2022 Q4 - Annual Report
ASLAN Pharmaceuticals(ASLN)2023-03-23 16:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------|------------------|-------------------------------------------------------| | Securities registered or to be registered, pursuant to Section 12(b) of the Act: \nTitle of each class | Trading Symbol | Name of each exchange on which registered | | American Depositary Shares ( ...